Greenspace Herbs is expanding into the United States with the launch of its Quantum Ayurveda platform, aiming to combine traditional Ayurvedic botanicals with clinically backed technology to enhance nutrient bioavailability. The initiative will be led by Gregory T. Arabatzis, who will focus on commercialisation, strategic partnerships, and market development in the U.S.
The platform targets the rapidly growing $50 billion U.S. dietary supplement market, positioning itself as a science-backed approach to wellness rooted in centuries-old Ayurvedic knowledge.
Shafiulla Hirehal Nuruddin said modern wellness consumers expect scientific validation and measurable results, adding that Quantum Ayurveda combines clinical research with traditional botanical expertise.
Arabatzis highlighted that the U.S. market values clinically substantiated innovation, and the company’s focus will now shift toward structured commercialisation, consumer education, and partnership development to scale adoption.
Bottom line: By merging Ayurveda with modern clinical research, Greenspace Herbs aims to position Quantum Ayurveda as a credible, science-driven wellness solution in the competitive U.S. supplements market.
